Skip to main content

Information for Patients with Aggressive Lymphomas

March 27, 2018

Topics Covered

We invite you to learn more about:

  • How your non-Hodgkin lymphoma (NHL) subtype influences your treatment plan
  • Current and emerging therapies for aggressive lymphomas
  • Managing side effects of treatment
  • The benefit of discussing quality-of-life concerns with your healthcare team



Mark Roschewski, MD
CDR, Commissioned Corps, Public Health Service
Lymphoid Malignancies Branch, Center for Cancer Research
National Cancer Institute, National Institutes of Health
Bethesda, MD

Audio Replay

Program Materials

Program Support

Support for this program provided by Genentech & Biogen, Pharmacyclics & Janssen, and The Leukemia & Lymphoma Society.



< Back to Webcasts